Bioenergy Devco Expands Executive Leadership Team
February 2, 2022 ...
February 2, 2022 ...
February 2, 2022 ...
...
Gaithersburg, Md., January 25, 2022 – Cartesian Therapeutics, a fully integrated clinical-stage biotechnology company pioneering RNA cell therapy in and beyond oncology, today announced that it has dosed the first patient in a Phase 1/2a multicenter clinical study evaluating Descartes-25 in patients with multiple myeloma. To the company’s knowledge, Descartes-25 is the first off-the-shelf RNA cell therapy to enter clinical trials for any cancer and marks the company’s fifth FDA Investigational New Drug (IND) allowance in five years. Descartes-25 is produced at Cartesian’s wholly owned cGMP manufacturing facility with the company’s proprietary RNA Armory® cell manufacturing platform. This platform now includes an internally developed, Part 1271-compliant Master Cell Bank of human umbilical cord Mesenchymal Stem Cells (MSC) that was used to engineer Descartes-25. ...
January 26, 2022 ...
Frederick County Office of Economic Development (OED) has launched a brand new website for all-things manufacturing in Frederick. “MadeInFrederickMD.com” is a one-stop shop for anyone interested in exploring the local industry, and features a business directory, an original video series, helpful resources, local job postings, upcoming events, and more! ...
Social Capital Builders, a resident company at the Maryland Innovation Center (MIC), announces the results of a proprietary survey designed to test the level of social capital literacy of Americans and the results aren’t good – Less than 50% of Americans show enough social capital literacy to effectively search for a job or properly assist young adults in their career development efforts. ...
Internet connectivity is a “must have” for people today. So it’s no surprise that more than 70 percent of multifamily housing residents surveyed recently cited pre-installed Wi-Fi solutions as an important amenity when moving into a new apartment or condominium, according to the 2020 NMHC/Kingsley Associates Apartment Resident Preferences Report. ...
The Frederick National Laboratory for Cancer Research (FNL) signed a new memorandum of understanding (MOU) with Frederick Community College (FCC) to establish a closer partnership to support the future science, technology, engineering and mathematics (STEM) workforce in Frederick. ...
Rare disease-focused REGENXBIO hit the ground running in 2022 with its developmental programs for Duchenne Muscular Dystrophy and wet age-related macular degeneration. The Maryland-based company received clearance from the U.S. Food and Drug Administration to initiate a first-in-human study of its gene therapy for the rare form of muscular dystrophy. ...